A longitudinal study of more than 10 million active-duty U.S. military personnel has produced some of the strongest evidence ...

A large-scale analysis of English hospital records spanning two decades has found that patients diagnosed with infectious ...

Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis. Today, our panel of experts will explore the treatment landscape and impact of multiple sclerosis ...

Tumefactive multiple sclerosis (MS) is a rare type of MS that causes a tumor-like lesion in your brain. This lesion can press on nearby parts of your brain, leading to many symptoms. Multiple ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.

Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

DelveInsight's“ Multiple Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the ...

When you live with multiple sclerosis (MS), the foods you eat can make a significant difference in your overall health. No specific diet can treat or cure MS, but many people find relief from symptoms ...